Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.80
Delayed Data
As of Jun 27
 -0.17 / -0.50%
Today’s Change
28.25
Today|||52-Week Range
36.46
+4.71%
Year-to-Date
Best Stocks to Buy in a Crash
Jun 27 / MotleyFool.com - Paid Partner Content
Stocks Benjamin Graham Would Buy Today
Jun 24 / GuruFocus News - Paid Partner Content
Sanofi Inks Deal to Swap Business with Boehringer Ingelheim
Jun 27 / Zacks.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
Jun 27 / Zacks.com - Paid Partner Content
Retrophin (RTRX) RE-024 Positive in Physician-Initiated Study
Jun 24 / Zacks.com - Paid Partner Content
10 Companies for Enterprising Dividend Investors - June
Jun 26 / GuruFocus News - Paid Partner Content
Why Pfizer (PFE) is a Great Stock to Buy for the Long Run
Jun 23 / Zacks.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
Corporate Share Buybacks Rise to Record Level in First Quarter
Jun 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close33.97
Today’s open33.80
Day’s range33.53 - 33.98
Volume29,846,683
Average volume (3 months)40,166,385
Market cap$206.0B
Dividend yield3.55%
Data as of 4:00pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+10.34%
Earnings growth (next 5 years)+6.80%
Revenue growth (last year)-1.52%
P/E ratio27.8
Price/Sales4.13
Price/Book3.24

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.14+0.18%
AGNPRAAllergan plc-20.68-2.53%
MRKMerck-0.57-1.02%
BMYBristol-Myers Squibb-0.29-0.41%
Data as of 4:02pm ET, 06/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.61
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs